Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Meuleman

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Journal of Hepatology|April 30, 2023
Comparison of HAV and HCV infections in vivo and in vitro reveals distinct patterns of innate immune evasion and activationOmbretta Colasanti, Rani Burm, Hao-En Huang, et al.
Journal of Hepatology|December 1, 2023
Corrigendum to "Comparison of HAV and HCV infections in vivo and in vitro reveals distinct patterns of innate immune evasion and activation" [J Hepatol (2023) 645-656]Ombretta Colasanti, Rani Burm, Hao-En Huang, et al.
Elife|November 20, 2014
A genetically attenuated malaria vaccine candidate based on P. falciparum b9/slarp gene-deficient sporozoitesBen C L van Schaijk, Ivo H J Ploemen, Takeshi Annoura, et al.
Hepatology (Baltimore, Md.)|August 8, 2015
Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1Paula M Perin, Sibylle Haid, Richard J P Brown, et al.
Journal of Medicinal Chemistry|December 15, 2010
Discovery of (7R)-14-cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine-11-carboxylic acid (MK-3281), a potent and orally bioavailable finger-loop inhibitor of the hepatitis C virus NS5B polymeraseFrank Narjes, Benedetta Crescenzi, Marco Ferrara, et al.
Hepatology (Baltimore, Md.)|August 17, 2022
Adeno-associated virus serotype 2 capsid variants for improved liver-directed gene therapyNadja Meumann, Marti Cabanes-Creus, Moritz Ertelt, et al.
Nature Communications|February 26, 2025
Broadly neutralizing antibodies isolated from HEV convalescents confer protective effects in human liver-chimeric miceGeorge Ssebyatika, Katja Dinkelborg, Luisa J Ströh, et al.
Gastroenterology|April 18, 2024
Phosphatidylinositol 4-Kinase III Alpha Governs Cytoskeletal Organization for Invasiveness of Liver Cancer CellsCong Si Tran, Julia Kersten, Jingyi Yan, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2020
Expansion, in vivo-ex vivo cycling, and genetic manipulation of primary human hepatocytesEleftherios Michailidis, Koen Vercauteren, Liliana Mancio-Silva, et al.
Cell Reports|September 14, 2022
Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric miceMohammad Kabbani, Eleftherios Michailidis, Sandra Steensels, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Journal of Hepatology|April 30, 2023
Comparison of HAV and HCV infections in vivo and in vitro reveals distinct patterns of innate immune evasion and activationOmbretta Colasanti, Rani Burm, Hao-En Huang, et al.
Journal of Hepatology|December 1, 2023
Corrigendum to "Comparison of HAV and HCV infections in vivo and in vitro reveals distinct patterns of innate immune evasion and activation" [J Hepatol (2023) 645-656]Ombretta Colasanti, Rani Burm, Hao-En Huang, et al.
Elife|November 20, 2014
A genetically attenuated malaria vaccine candidate based on P. falciparum b9/slarp gene-deficient sporozoitesBen C L van Schaijk, Ivo H J Ploemen, Takeshi Annoura, et al.
Hepatology (Baltimore, Md.)|August 8, 2015
Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1Paula M Perin, Sibylle Haid, Richard J P Brown, et al.
Journal of Medicinal Chemistry|December 15, 2010
Discovery of (7R)-14-cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine-11-carboxylic acid (MK-3281), a potent and orally bioavailable finger-loop inhibitor of the hepatitis C virus NS5B polymeraseFrank Narjes, Benedetta Crescenzi, Marco Ferrara, et al.
Hepatology (Baltimore, Md.)|August 17, 2022
Adeno-associated virus serotype 2 capsid variants for improved liver-directed gene therapyNadja Meumann, Marti Cabanes-Creus, Moritz Ertelt, et al.
Nature Communications|February 26, 2025
Broadly neutralizing antibodies isolated from HEV convalescents confer protective effects in human liver-chimeric miceGeorge Ssebyatika, Katja Dinkelborg, Luisa J Ströh, et al.
Gastroenterology|April 18, 2024
Phosphatidylinositol 4-Kinase III Alpha Governs Cytoskeletal Organization for Invasiveness of Liver Cancer CellsCong Si Tran, Julia Kersten, Jingyi Yan, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2020
Expansion, in vivo-ex vivo cycling, and genetic manipulation of primary human hepatocytesEleftherios Michailidis, Koen Vercauteren, Liliana Mancio-Silva, et al.
Cell Reports|September 14, 2022
Human hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric miceMohammad Kabbani, Eleftherios Michailidis, Sandra Steensels, et al.
Pageof 13